FDA inspection
Ascensia Diabetes Care US, Inc.: FDA inspection ending Aug 7, 2017
FDA inspection 1022643 · No Action Indicated (NAI) · Valhalla, NY
Key facts
| Inspection ID | 1022643 |
|---|---|
| Firm | Ascensia Diabetes Care US, Inc. |
| FEI number | 1810909 |
| Address | 100 Summit Lake Dr |
| City | Valhalla |
| State | NY |
| ZIP | 10595 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Aug 7, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data